Child pages
  • Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer (AHEP0731)

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 2 Next »

Summary

This phase III trial studies the side effects and how well risk-based therapy works in treating younger patients with newly diagnosed liver cancer. Surgery, chemotherapy drugs (cancer fighting medicines), and when necessary, liver transplant, are the main current treatments for hepatoblastoma. The stage of the cancer is one factor used to decide the best treatment. Treating patients according to the risk group they are in may help get rid of the cancer, keep it from coming back, and decrease the side effects of chemotherapy.

Acknowledgements

We would like to acknowledge the individuals and institutions that have provided data for this collection:

  • Hospital/Institution Name city, state, country - Special thanks to First Last Names, degree PhD, MD, etc from the Department of xxxxxx, Additional Names from same location.

  • Continue with any names from additional submitting sites if collection consists of more that one.

Data Access

Data TypeDownload all or Query/Filter

Images, Segmentations, and Radiation Therapy Structures/Doses/Plans (DICOM, XX.X GB)

<< latter two items only if DICOM SEG/RTSTRUCT/RTDOSE/PLAN exist >>

   

(Download requires the NBIA Data Retriever)

Tissue Slide Images (SVS, XX.X GB)
Clinical data (CSV)
Genomics (web)

Click the Versions tab for more info about data releases.

Please contact help@cancerimagingarchive.net  with any questions regarding usage.

Detailed Description

Image Statistics


Modalities


Number of Patients

233

Number of Studies


Number of Series


Number of Images


Images Size (GB)

<< Add any additional information as needed below. Likely would be something from site. >>


Citations & Data Usage Policy

Users of this data must abide by the TCIA Data Usage Policy and the Creative Commons Attribution 4.0 International License under which it has been published. Attribution should include references to the following citations:

Users of this data must abide by the TCIA Data Usage Policy and the Creative Commons Attribution-NonCommercial 4.0 International License under which it has been published. Attribution should include references to the following citations:

Data Citation

DOI goes here. Create using Datacite with information from Collection Approval form

Publication Citation

We ask on the proposal form if they have ONE traditional publication they'd like users to cite.

Acknowledgement

Only if they ask for special acknowledgments like funding sources, grant numbers, etc in their proposal.

TCIA Citation

Clark K, Vendt B, Smith K, Freymann J, Kirby J, Koppel P, Moore S, Phillips S, Maffitt D, Pringle M, Tarbox L, Prior F. The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository, Journal of Digital Imaging, Volume 26, Number 6, December, 2013, pp 1045-1057. DOI: 10.1007/s10278-013-9622-7

Other Publications Using This Data

TCIA maintains a list of publications which leverage TCIA data. If you have a manuscript you'd like to add please contact the TCIA Helpdesk.

Version X (Current): Updated yyyy/mm/dd

Data TypeDownload all or Query/Filter
Images (DICOM, xx.x GB)
Clinical Data (CSV)Link
Other (format)

<< One or two sentences about what you changed since last version.  No note required for version 1. >> 



  • No labels